Cardioptimus Overview

  • Founded
  • 2012
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Latest Deal Amount
  • $50K
Latest Deal Amount
  • Investors
  • 1

Cardioptimus General Information


Developer of an embolic deflection device designed to aid in transcatheter aortic valve replacement. The company's device uses state-of-the-art removable stent, enabling doctors to improve patient outcomes during TAVR (transcatheter aortic valve replacement) and cardiac surgery procedures.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Other Devices and Supplies
Primary Office
  • 1601 South Providence Road
  • Columbia, MO 65211
  • United States
+1 (417) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cardioptimus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC $50K 0000 Completed Startup
To view Cardioptimus’s complete valuation and funding history, request access »

Cardioptimus Executive Team (5)

Name Title Board Seat Contact Info
Raja Gopaldas MD Co-Founder
Kyle Rood Co-Founder
To view Cardioptimus’s complete executive team members history, request access »

Cardioptimus Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Missouri Technology Corporation Venture Capital Minority 000 0000 000000 0
To view Cardioptimus’s complete investors history, request access »